Delivery Order SPE2DB22D1106-SPE2DB24FEGW5
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,555,735,929 units of Dupixent 300 mg/2 ml syringes. The $105,406.78 award, with a completion date of December 17, 2021, supports the provision of pharmaceuticals and critical care supplies for military treatment programs and facilities. Amerisourcebergen Drug Corp is a prime contractor that has received...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, for the supply of Dupixent 300 mg/2 ml syringes. The contract has a potential value of $4,175.56 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which does not have a set-aside designation....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Dupixent 300 mg/2 ml syringes. The award, valued at $1,652.35, has an ultimate completion date of April 15, 2024. The contract is not associated with any set-aside designations. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Dupixent 300 mg/2 ml syringes. The contract, valued at $23,211.99, has an ultimate completion date of June 7, 2022. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,652.35 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The order is for Dupixent 200 mg/1.14 ml syringes, and has an ultimate completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,220,373 units of the pharmaceutical product Dupixent 200 mg/1.14 ml syringe. The contract has a firm fixed price of $6,715.26 and a completion date of July 23, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several indefinite delivery contracts with government agencies, including a $999,999,999 contract with DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DX15D1053|SPE2DX24F6KHK) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Dupixent 200 mg/1.14 ml pen. The delivery order, valued at $2,703.29, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply Dupixent 300 mg/2 ml syringes. The $6,407.20 firm fixed-price contract has a completion date of July 8, 2024. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which enables the agency to efficiently procure a range of pharmaceutical products and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. The $18,641.02 firm fixed-price contract has an ultimate completion date of August 14, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,980.54 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Dupixent 300 mg/2 ml syringes, with a period of performance through April 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEGW5Delivery Order
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,083,909 units of the prescription pharmaceutical Dupixent 200 mg/1.14 ml syringes. The $6,609.40 contract has a performance period through March 27, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor on this award, which is not associated with a larger contract vehicle. No set-aside designations were used. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications valued up to $750,000 through May 2024, as well as a single award indefinite delivery contract with DLA Troop Support Medical with a potential value of $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 3/26/24 |